U.S. Telecom Services and Carriers Stock News

NYSE:COR
NYSE:CORHealthcare

Cencora Expands Retina Network As CFO Retirement Opens New Chapter

Cencora (NYSE:COR) has signed a binding agreement to acquire the retina division of EyeSouth Partners, expanding its Retina Consultants of America network. The transaction centers on advanced retina care services and is intended to deepen Cencora's presence in ophthalmology-focused healthcare offerings. The company also announced the planned retirement of Chief Financial Officer James F. Cleary and has initiated an executive search for his successor. Cencora operates across pharmaceutical...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

How Short Seller Claims on Transparency and Regulation Will Impact MakeMyTrip (MMYT) Investors

In late March 2026, activist short seller Morpheus Research released a report alleging that MakeMyTrip violated regulatory bans on price parity clauses and raised questions about accounting practices, including the treatment of a receivable from insolvent airline Go Air. The report also highlighted a large gap between MakeMyTrip’s adjusted profits and IFRS figures, bringing renewed attention to the company’s financial transparency and regulatory exposure. We’ll now explore how these...
NasdaqGM:KALV
NasdaqGM:KALVBiotechs

Why KalVista Pharmaceuticals (KALV) Is Up 5.0% After Promising Pediatric EKTERLY HAE Trial Results – And What's Next

KalVista Pharmaceuticals recently reported new interim results from its KONFIDENT-KID trial, showing that EKTERLY (sebetralstat) oral disintegrating tablets treated 172 hereditary angioedema attacks in 33 children aged 2–11 with rapid symptom relief and no serious or treatment-related adverse events. The data highlight how an easy-to-administer oral option could address a major gap in pediatric hereditary angioedema care, where current on-demand treatment for young patients in the US is...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Assessing Adobe’s Valuation After Analyst Downgrades And CEO Retirement Announcement

Analyst downgrades and CEO exit put Adobe’s risk profile in focus Recent downgrades of Adobe (ADBE) and the planned retirement of long-serving CEO Shantanu Narayen have put leadership, pricing power, and AI competition at the center of the stock’s story for investors. Several research houses, including William Blair, have questioned how resilient Adobe’s Creative Cloud economics are as free or low cost design tools and AI native rivals gain traction, even as the company continues to invest...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

CME Group’s Record Volumes And 24 7 Push Test Current Valuation

CME Group (NasdaqGS:CME) reports record trading volumes across all product categories. The company launches 24/7 trading for regulated cryptocurrency futures and options. CME partners with BMO and Google Cloud to roll out 24/7 tokenized cash settlement for institutional clients. CME Group, trading at $305.11, is drawing attention after reporting all time record volumes across multiple asset classes and pushing further into round the clock trading. The stock is up 13.1% year to date and...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Assessing Millicom International Cellular’s Valuation After A Strong Multi Year Share Price Run

Millicom International Cellular: Recent Performance Snapshot Millicom International Cellular (TIGO) has caught investor attention after a strong run, with the stock showing gains over the past week, month and past 3 months that outpace its recent daily move. With a recent close of $79.64 and a market value of about $12.88b, investors are weighing this price action against Millicom’s reported $5,819.0 in revenue, $1,316.0 in net income and a value score of 5. See our latest analysis for...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Fermi (FRMI) Is Down 11.9% After Funding Massive Project Matador Build-Out For AI Power Demand

Fermi Inc., in partnership with the Texas Tech University System, recently arranged up to US$156.25 million in unsecured debt financing alongside a US$165.00 million equipment loan, while advancing permitting and regulatory filings for its large-scale Project Matador energy campus in Texas. These moves, paired with a US$486.38 million net loss in 2025 and plans for up to ~17 GW of generation including nuclear, gas, solar, and batteries, highlight Fermi’s push to build a privately funded...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Valuation Check As Foundayo Oral GLP 1 Approval Lifts Obesity Growth Story

Eli Lilly (LLY) has surged back into the spotlight after the FDA approved Foundayo, a once daily oral GLP 1 pill for obesity that expands the company’s weight loss portfolio beyond injectables. See our latest analysis for Eli Lilly. The FDA approval of Foundayo comes after an already active period for Eli Lilly, with recent acquisitions in neuroscience and new data across dermatology and psoriatic arthritis. Over the same time, the share price has seen a 30 day return of 7.16% and a 90 day...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Is Pool (POOL) Offering Value After A 34% One Year Share Price Decline

If you are wondering whether Pool's current share price lines up with its underlying value, this article walks through the numbers so you can judge that for yourself. Pool last closed at US$202.93, with returns of 0.9% over 7 days, an 8.3% decline over 30 days, an 11.7% decline year to date and a 34.1% decline over 1 year that many investors are watching closely. Over the past few months, coverage of Pool has focused on how the share price performance compares with broader retail...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Class Actions Challenge Nektar Trial Disclosures And Investor Confidence Narrative

Multiple law firms and investor groups have launched class action lawsuits against Nektar Therapeutics (NasdaqCM:NKTR). The suits allege securities fraud tied to protocol violations in the Phase 2b REZOLVE-AA trial. Claims focus on whether Nektar misled investors about enrollment and data integrity for this alopecia areata study. These legal actions introduce new uncertainty around the company’s clinical programs and governance practices. Nektar Therapeutics focuses on developing drug...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast Blackouts And NVIDIA AI Push Reshape Investor View On CMCSA

Comcast Xfinity is in a carriage dispute with E.W. Scripps that has triggered immediate blackouts of major broadcast networks and key sports programming in several U.S. markets. At the same time, Comcast has entered a partnership with NVIDIA to deploy real-time AI applications at the network edge across parts of its infrastructure. Both developments are material for NasdaqGS:CMCSA investors because they touch core video services, customer experience, and future network...
NYSE:ONON
NYSE:ONONLuxury

Will On Holding’s Founder-Led Pivot and New CFO Shape a Different Narrative for (ONON)?

In late March 2026, On Holding AG announced a leadership shake-up effective May 1, 2026, with co-founders David Allemann and Caspar Coppetti becoming Co-CEOs, long-time CEO and former CFO Martin Hoffmann stepping down into an advisory role, and Frank Sluis joining as the new CFO. The reorganization places the founders directly in charge of day-to-day execution while elevating President & COO Scott Maguire to oversee the entire value chain, potentially tightening the link between product...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

A Look At SEI Investments (SEIC) Valuation After Recent Share Price Weakness

Why SEI Investments Is On Investors’ Radar Recent share performance has put SEI Investments (SEIC) back in focus for investors, with the stock showing a 7.2% decline over the past 3 months and a 6.8% decline over the past month. See our latest analysis for SEI Investments. The recent 1 day share price return of a 1.32% decline and a year to date share price return of a 7.23% decline contrast with a 1 year total shareholder return of 6.04%. This suggests that shorter term momentum has faded...
NYSE:FDS
NYSE:FDSCapital Markets

FactSet (FDS) Is Up 16.0% After Raising 2026 Outlook and Launching New AI Banking Platform

In late March 2026, FactSet Research Systems reported Q2 results showing higher sales than a year earlier, raised its full-year 2026 revenue and earnings guidance, continued buying back shares under its existing repurchase program, and advanced multiple AI initiatives including AI-enabled Document Search and the alpha launch of FactSet AI for Banking with Finster AI. These developments highlight FactSet’s effort to reposition itself as an AI-enabled data and workflow infrastructure provider,...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

Assessing Rambus (RMBS) Valuation After Concentrated Insider Selling And Semiconductor Sector Weakness

Rambus (RMBS) has come under pressure after two executives sold a combined US$4.6 million in stock in early March, a concentrated bout of insider selling that has unsettled some investors. See our latest analysis for Rambus. Despite the recent insider sales and sector weakness that pushed the share price lower in recent months, Rambus now trades at US$93.03, with a 6.21% 1 month share price return but a 6.30% share price decline year to date, set against a very large 101.58% 1 year total...
NYSE:LNG
NYSE:LNGOil and Gas

What Cheniere Energy (LNG)'s Long‑Dated LNG Deals And Buybacks Mean For Shareholders

Citi recently raised its outlook on Cheniere Energy, highlighting how ongoing geopolitical disruption in the Middle East has reinforced long-term demand for secure U.S. LNG supplies, supported by the company’s expanding capacity and high contracted volumes through 2030. A key insight is that Cheniere is converting these geopolitical tailwinds into contracted cash flows, underlined by new long-dated deals such as its supply agreement with CPC Corporation of Taiwan running through 2050 and a...
NasdaqGS:CALM
NasdaqGS:CALMFood

How Investors May Respond To Cal-Maine Foods (CALM) Slower Sales, Smaller Dividend And Specialty Egg Pivot

In early April 2026, Cal-Maine Foods reported third-quarter fiscal 2026 results showing sharply lower year-on-year sales and net income as egg prices eased, alongside a reduced US$0.36 per-share variable dividend and confirmation it is actively seeking acquisitions after buying assets from Creighton Brothers and Crystal Lake. At the same time, the company accelerated its mix shift toward higher-value specialty eggs and prepared foods, which now contribute just over half of net sales, while...
NYSE:TNET
NYSE:TNETProfessional Services

A Look At TriNet Group (TNET) Valuation After New AI HR Platform And Global Workforce Tools

TriNet Group (TNET) has put fresh attention on its stock after unveiling an expanded HR platform that adds AI powered support, global workforce tools, IT asset management, and new retirement plan integrations. See our latest analysis for TriNet Group. The new AI focused HR tools arrive after a tough period for investors, with the 90 day share price return of TriNet Group sitting at a 33.88% decline and the 1 year total shareholder return at a 50.01% decline. As a result, recent product news...
NYSE:URI
NYSE:URITrade Distributors

Is URI’s Earnings Miss and Richer Payout Plan Altering The Investment Case For United Rentals?

United Rentals recently reported past fourth-quarter 2025 results with revenue and earnings per share below analyst expectations, while outlining expanded 2026 share repurchases, a 10% dividend increase, and specific revenue growth targets. This combination of an earnings miss alongside more generous capital returns and cost pressures has sharpened investor focus on the balance between short-term challenges and the company’s longer-term plans. We’ll now examine how the earnings miss and...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel’s SambaNova Stake Grows To 9% As AI And Governance Intersect

Intel (NasdaqGS:INTC) has added US$15 million to its investment in AI chip startup SambaNova Systems. This move brings Intel's ownership stake in SambaNova to 9%. SambaNova is chaired by Intel CEO Lip-Bu Tan, raising potential questions about governance and conflicts of interest. Intel is expanding its presence in AI infrastructure as demand grows for computing power to support complex models and inference workloads. For investors watching how large chipmakers position around AI, the...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Do Record Q3 Results And New Hard Beverages Change The Bull Case For Tilray Brands (TLRY)?

Tilray Brands, Inc. reported past third-quarter 2026 results with sales of US$206.73 million and a net loss of US$26.57 million, alongside new ready-to-drink Popsicle Hard beverages and Shock Top High Voltage beer launches in the U.S. market. The combination of higher revenue, sharply reduced losses versus a very large prior-year net loss, and an expanding portfolio of branded alcoholic drinks underscores Tilray’s push to balance its cannabis operations with a broader consumer beverage...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Does Legal Scrutiny of Fiserv’s 2025 Guidance Assumptions Change The Bull Case For Fiserv (FISV)?

In recent months, Fiserv has come under legal scrutiny, with a class action complaint and related investigations alleging that management issued misleading statements about key initiatives and based revised 2025 guidance on difficult-to-achieve assumptions, potentially affecting long-term shareholders. At the same time, the latest Fiserv Small Business Index for March 2026 suggests a resilient small business backdrop, adding complexity for investors weighing legal risks against an otherwise...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

A Look At PayPal Holdings (PYPL) Valuation As Board Changes And Lawsuits Draw Investor Attention

PayPal Holdings (PYPL) is back in focus after appointing Alyssa Henry, former head of Block’s Square business, to its board, as the company manages leadership turnover and active securities class action lawsuits. See our latest analysis for PayPal Holdings. Despite the board refresh and ongoing lawsuits drawing fresh attention, PayPal’s recent 1-day share price return of 1.59% sits against a 90-day share price return decline of 22.02% and a 5-year total shareholder return loss of 82.77%. This...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Fuel Hedge Reshapes Cruise Line Cost And Margin Story

Royal Caribbean Cruises (NYSE:RCL) has hedged about 60% of its 2026 fuel needs, partly insulating the company from recent crude oil price spikes. The move contrasts with competitors Carnival and Norwegian Cruise Line, which are experiencing more direct cost pressure from higher fuel prices. The company’s hedging activity is drawing attention as fuel cost volatility becomes a key focus for cruise investors. Royal Caribbean Cruises, trading at around $273.59, has risen 47.2% over the past...